Roche
Presence
Roche is one of the...
- Forbes Global 2000 (#76);
- Fortune 500 Europe (#38);
- Global Fortune 500 (#184);
- Russell 3000;
- Stoxx 600;
- Swiss market index.
Roche is a company listed under the stock ticker ROG (CH).
Roche has a direct presence in 22 countries.Roche has 37 subsidiaries including Cenexi, Chugai Pharmaceutical and Flatiron Health.
They are in:
- Pharmaceuticals68%
- Biotechnology26%
- Other5%
Acquisition, funding and merger involving Roche.
- Roche has announced the acquisition of Carmot Therapeutics (posted on December 7 2023).
Executives
View the org chart displaying its 259 main executives
Most searched biographies at Roche
- Thomas Schinecker, Group Chief Executive Officer
- Severin Schwan, Chairman of the Board
- Richard Lifton, Director
Popular executive movements at Roche
- Boris Zaïtra who is Head of Group Business Development, will be promoted to Member of the Executive Committee and Head of Corporate Business Development on Jul. 1, 2024 (posted on May 27 2024).
- James Sabry, Member of the Executive Committee and Global Head of Pharma Partnering, will retire on Jul. 1, 2024 (posted on May 27 2024).
Create your alert
to follow the executive moves at Roche.
Pharmaceuticals
Roche has 1,857 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).
Popular M&A news in Pharmaceuticals
- LakeShore Biopharma will change its company name to LakeShore Biopharma on May 24, 2024. (posted on May 25 2024).
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Roche
Social media about Roche
- Roche on Wikipedia, Google News & Yahoo Finance
- Roche on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Severin Schwan 
